Research
Why research-use-only sellers are not compared here
A large parallel market sells the same molecules with a label saying they are not for human use. This comparison does not rank those sellers, and the reason is what the boards claim to measure.
Answer first: they are not the thing these boards rank
Every board on this site says what it ranks, in the same words each time: providers dispensing to US patients through a telehealth intake. That sentence is not decoration. It names three things a seller must have — a prescriber, a dispensing pharmacy, and an intake that reaches both — and the score is built from what a seller publishes about them.
A research-use-only vendor has none of the three. There is no prescriber, because nothing is being prescribed. There is no dispensing pharmacy, because nothing is being dispensed. There is no intake, because the transaction is a purchase rather than a consultation. Scoring one against a rubric built for the other would produce a number, and the number would mean nothing.
So the exclusion is not a judgement about those sellers. It is a statement about what these boards measure, and about not quietly changing the question a page claims to answer.
What the label on those sites actually says
These vendors describe their products as intended for laboratory or research use and state that they are not for human consumption. That sentence is usually on the product page, in the terms, or both, and it is the seller describing its own goods.
It is worth reading literally rather than as a formality. A product sold on those terms is not offered as a medicine, is not accompanied by a prescriber, and carries no claim from the seller that it is fit for a person. Whatever else is true, the seller has told you what it is selling.
A reader who encounters one of these sites has therefore been told something useful by the site itself. This comparison has nothing to add to that sentence, and it is not this site’s place to argue with it in either direction.
Why the price looks different, and why that comparison does not hold
Figures in that market are often far below the programs compared here, and the gap is easy to read as the same product priced two ways. It is not.
A telehealth program’s figure covers a consultation, a prescriber’s time, a pharmacy’s preparation and dispensing, and shipping — the price of a service that ends with a prescribed product. A research-use figure covers a shipped item and nothing else, because nothing else was offered.
Setting one against the other compares a service against a purchase. This site refuses that comparison for the same reason it refuses to compare a per-vial figure against a monthly program: the two answer different questions, and putting them in one column would make the cheaper number look like the better deal by hiding what the other one bought.
What this means for a reader who has already found one
This article does not tell anyone what to do, and it cannot assess any individual product or seller. What it can do is name the questions that the boards on this site are built to answer, so a reader can see which of them the other market does not answer at all.
Who reviewed this order, and can they be named? Which pharmacy prepared it? What is being represented about what is in the vial, and by whom? Those are the checkable facts this comparison scores, and they are checkable precisely because a telehealth program publishes claims about them.
Where those questions have no answer because nobody has made a claim, there is nothing for this site to verify — and a page that scored such a seller anyway would be manufacturing confidence rather than measuring it.
The rule, stated so it can be checked
A seller appears on these boards when it offers a product to US patients through a telehealth intake, whether it dispenses an approved product or a compounded preparation, and whether or not it publishes a price.
A seller does not appear when the transaction is a purchase of an item marketed as not for human use. That is the whole of the rule, and it is applied to the class rather than case by case, so no individual vendor is being singled out and no reader has to guess where the line falls.
If that boundary ever moves, it will move here first, in writing, with the reason attached.
Key takeaways
- Every board here ranks providers dispensing to US patients through a telehealth intake — a prescriber, a pharmacy and an intake that reaches both.
- A research-use-only vendor has none of those three, so the rubric that produces a score has nothing to measure.
- Those sellers state on their own pages that their products are not for human consumption; that sentence is the seller describing its own goods.
- Their figures are lower because they cover a shipped item rather than a service that ends with a prescribed product — a purchase against a service, not one product priced twice.
- The exclusion is applied to the class, not vendor by vendor, so no seller is singled out and the line is checkable.
- This site names none of them, because naming one would act as a pointer to it.
Frequently asked questions
Does excluding these sellers mean this site judges them unsafe?
No. The site makes no assessment of them at all, which is the point. They sit outside what these boards measure, and scoring them against a rubric built for telehealth programs would produce a number with nothing behind it.
Why not add them with a warning label instead?
Because a row on a board is a comparison, and a warning does not undo that. Listing them beside prescribed programs would present the two as alternatives on one axis, which is the confusion the exclusion exists to prevent.
They sell the same molecules — why is that not the same product?
A molecule name is not a product. What a telehealth program charges for includes a prescriber, a pharmacy and a dispensing step; what a research-use vendor ships is an item sold on the stated basis that it is not for human use. Those are different transactions.
Does this site name any of these vendors?
No. Naming one would function as a pointer to it, and the argument here is that they are outside what this site assesses. Readers who have found one are better served by understanding the label on it.
Where is the boundary written down?
On every board, in the line describing what it ranks: providers dispensing to US patients through a telehealth intake. This article restates that line and explains what it excludes.